Chicago Lab Services INC

Chicago Lab Services INC was paid $1.40M by Medicaid between Sep 2021 and Dec 2024, across 86 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 25% of everything it billed.

Compared with peers

Next to other Clinical Pathology Physician providers in Illinois

Rank by total paid#1 of 8

Median peer was paid$58K

This provider vs. median24×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	343	$11K
2022	14,696	$323K
2023	32,945	$539K
2024incomplete	37,774	$525K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	25%	5,994	3,845	$355K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	11%	1,489	1,308	$149K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	8.4%	6,097	3,923	$118K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	7.8%	5,628	3,759	$108K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.2%	1,083	810	$45K
84443	Thyroid stimulating hormone (TSH)	3.0%	2,959	2,272	$41K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	2.7%	481	267	$38K
80053	Comprehensive metabolic panel	2.0%	3,279	2,551	$28K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.8%	684	545	$26K
82533		1.8%	2,199	1,648	$25K
86256		1.7%	1,551	1,112	$24K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.6%	620	495	$23K

74 more codes

82607		1.5%	2,120	$21K
84480		1.4%	2,460	$20K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.4%	1,706	$19K
83970		1.3%	688	$18K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	3,392	$17K
80061	Lipid panel	1.1%	2,616	$16K
82746		1.1%	1,624	$15K
82728		<1%	2,014	$14K
87529		<1%	291	$13K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,342	$13K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	531	$13K
83540		<1%	2,254	$12K
84439		<1%	1,617	$12K
86430		<1%	2,224	$12K
82150		<1%	2,065	$11K
83735		<1%	1,914	$10K
86141		<1%	908	$10K
84402		<1%	570	$10K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	175	$9K
83550		<1%	1,268	$8K
84153		<1%	699	$8K
83090		<1%	672	$8K
83001		<1%	487	$8K
84550		<1%	2,118	$8K
86060		<1%	1,132	$7K
82977		<1%	1,719	$7K
87563		<1%	339	$7K
84146		<1%	450	$5K
84466		<1%	680	$5K
83002		<1%	479	$5K
86140		<1%	1,220	$5K
84144		<1%	427	$5K
84436		<1%	851	$5K
86063		<1%	753	$5K
82670		<1%	338	$5K
84100		<1%	1,133	$5K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	43	$4K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	116	$4K
86039		<1%	436	$4K
86038		<1%	335	$4K
82627		<1%	269	$4K
82043		<1%	982	$4K
82747		<1%	281	$3K
83690		<1%	531	$3K
87641		<1%	98	$3K
87640		<1%	97	$3K
87500		<1%	116	$2K
84702		<1%	196	$2K
82787		<1%	231	$1K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	38	$981.48
86803		<1%	54	$848.24
82550		<1%	165	$842.54
86592		<1%	220	$821.57
81001		<1%	320	$816.24
81000		<1%	327	$813.71
81015		<1%	326	$740.45
85651		<1%	170	$706.02
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	241	$647.38
87081		<1%	116	$490.84
87340		<1%	37	$427.98
85652		<1%	158	$394.65
85610		<1%	133	$357.82
86706		<1%	26	$338.18
84075		<1%	106	$318.44
83615		<1%	56	$277.68
86701		<1%	22	$252.21
86702		<1%	22	$198.41
36415	Collection of venous blood by venipuncture	<1%	892	$176.24
84478		<1%	33	$149.90
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	126	$146.21
83718		<1%	20	$141.07
83721		<1%	14	$129.51
82465		<1%	32	$117.72
82044		<1%	33	$110.41

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHABIB, SHAISTA (PRESIDENT)